Side-by-side comparison of AI visibility scores, market position, and capabilities
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Uplight-acquired DERMS and VPP platform managing 3,500 MW of flexibility for National Grid and NextEra; $160M raised at $22.9M revenue enabling utilities to orchestrate batteries, EVs, and smart loads for grid balancing.
AutoGrid is a Redwood City, California-based energy flexibility management software company — acquired by Uplight (Boulder-based energy technology company) in 2023 after raising $160 million from investors including GE Ventures, Envision Energy, Eneco, and ENGIE — providing utilities, energy retailers, and grid operators with AI-powered distributed energy resource management (DERMS), virtual power plant (VPP) orchestration, and demand flexibility platforms that aggregate and dispatch batteries, electric vehicles, HVAC systems, and industrial loads to balance grid supply and demand in real time. AutoGrid generated $22.9 million in revenue prior to acquisition and deployed technology managing 3,500 MW of flexibility capacity and 37,000 MWh of energy storage, serving customers including National Grid, NextEra Energy, and Pacific Gas & Electric.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.